TRCT
RMD icon

Tower Research Capital (TRC)’s ResMed RMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Sell
2,694
-394
-13% -$98.2K 0.02% 794
2025
Q4 		$744K Buy
3,088
+1,364
+79% +$349K 0.02% 620
2025
Q3 		$472K Sell
1,724
-7,485
-81% -$2.04M 0.01% 902
2025
Q2 		$2.38M Buy
9,209
+3,934
+75% +$938K 0.06% 275
2025
Q1 		$1.16M Sell
5,275
-3,170
-38% -$740K 0.03% 448
2024
Q4 		$1.93M Buy
8,445
+5,032
+147% +$1.21M 0.04% 378
2024
Q3 		$833K Sell
3,413
-6,322
-65% -$1.41M 0.02% 625
2024
Q2 		$1.86M Buy
9,735
+7,062
+264% +$1.43M 0.03% 458
2024
Q1 		$529K Sell
2,673
-19,280
-88% -$3.53M 0.01% 834
2023
Q4 		$3.78M Buy
21,953
+15,467
+238% +$2.38M 0.05% 329
2023
Q3 		$959K Sell
6,486
-55
-0.8% -$9.95K 0.03% 560
2023
Q2 		$1.43M Buy
6,541
+4,027
+160% +$898K 0.05% 331
2023
Q1 		$550K Sell
2,514
-176
-7% -$38.2K 0.02% 770
2022
Q4 		$560K Sell
2,690
-7,939
-75% -$1.74M 0.02% 645
2022
Q3 		$2.32M Buy
10,629
+3,970
+60% +$904K 0.04% 376
2022
Q2 		$1.4M Sell
6,659
-10,670
-62% -$2.27M 0.03% 511
2022
Q1 		$4.2M Buy
17,329
+1,369
+9% +$331K 0.04% 356
2021
Q4 		$4.16M Buy
15,960
+12,303
+336% +$3.19M 0.07% 232
2021
Q3 		$964K Sell
3,657
-10,958
-75% -$3M 0.02% 560
2021
Q2 		$3.6M Buy
14,615
+3,345
+30% +$703K 0.09% 152
2021
Q1 		$2.19M Buy
11,270
+5,787
+106% +$1.16M 0.04% 451
2020
Q4 		$1.17M Sell
5,483
-2,611
-32% -$521K 0.04% 441
2020
Q3 		$1.39M Buy
8,094
+6,953
+609% +$1.28M 0.02% 683
2020
Q2 		$219K Sell
1,141
-3,299
-74% -$540K 0.01% 1714
2020
Q1 		$654K Buy
4,440
+2,817
+174% +$449K 0.04% 333
2019
Q4 		$251K Sell
1,623
-3,093
-66% -$446K 0.02% 500
2019
Q3 		$637K Buy
+4,716
New +$618K 0.04% 478
2019
Q2 		– Sell
-2,809
Closed -$292K – 4189
2019
Q1 		$292K Buy
2,809
+470
+20% +$48.5K 0.02% 953
2018
Q4 		$266K Sell
2,339
-197
-8% -$21.1K 0.02% 600
2018
Q3 		$292K Sell
2,536
-4,816
-66% -$528K 0.02% 768
2018
Q2 		$762K Buy
+7,352
New +$744K 0.04% 455
2018
Q1 		– Sell
-843
Closed -$71K – 3745
2017
Q4 		$71K Buy
+843
New +$69.6K 0.01% 1092
2017
Q2 		– Sell
-11
Closed -$1K – 3326
2017
Q1 		$1K Sell
11
-665
-98% -$46K ﹤0.01% 2834
2016
Q4 		$42K Sell
676
-7,195
-91% -$441K ﹤0.01% 1548
2016
Q3 		$510K Buy
7,871
+3,032
+63% +$202K 0.05% 160
2016
Q2 		$306K Buy
+4,839
New +$285K 0.03% 438
2016
Q1 		– Sell
-200
Closed -$11K – 4796
2015
Q4 		$11K Sell
200
-3,707
-95% -$209K ﹤0.01% 2023
2015
Q3 		$199K Buy
+3,907
New +$210K 0.02% 292
2015
Q2 		– Sell
-1,079
Closed -$78K – 4924
2015
Q1 		$78K Sell
1,079
-811
-43% -$52.7K 0.01% 1100
2014
Q4 		$106K Buy
1,890
+1,678
+792% +$87.6K 0.01% 581
2014
Q3 		$10K Sell
212
-12,003
-98% -$611K ﹤0.01% 2835
2014
Q2 		$619K Buy
12,215
+11,920
+4,041% +$591K 0.08% 196
2014
Q1 		$13K Sell
295
-1,836
-86% -$82.5K ﹤0.01% 2355
2013
Q4 		$100K Sell
2,131
-170
-7% -$8.61K 0.02% 864
2013
Q3 		$122K Sell
2,301
-739
-24% -$35.8K 0.01% 1117
2013
Q2 		$137K Buy
+3,040
New +$144K 0.01% 380

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tower Research Capital (TRC)'s RMD Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its ResMed (RMD) stake by 13% in Q1 2026, selling an estimated $98.2K and leaving 2,694 shares worth $605K. The position accounts for 0.02% of the portfolio, ranked #794.

Tower Research Capital (TRC) first reported a position in RMD in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.2M in Q1 2022. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Tower Research Capital (TRC) held 2,694 shares of ResMed worth $605K as of Q1 2026.
  • Tower Research Capital (TRC) sold 394 ResMed shares in Q1 2026, an estimated $98.2K.
  • ResMed made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #794 holding.
  • Tower Research Capital (TRC) first reported a position in ResMed in Q2 2013 and has held it in 46 quarters since.
  • Tower Research Capital (TRC)'s ResMed position peaked at $4.2M in Q1 2022.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.